BRITISH SOCIETY FOR HAEMATOLOGY

64th Annual Scientific Meeting of the British Society for Haematology

 

28-30 April Liverpool
Close
N. Poster
Poster title
Applicant name
Status
  1-EP Characterization of Acute Promyelocytic Leukaemia: follow up study at a tertiary care center Maymoona Suhail Received Received
  2-EP c-MYC gene expression in hematological malignancies: Diagnostic and prognostic value Ifeyinwa Okafor Received Received
  3-EP RELATIONSHIP OF ENDOGENOUS CYTOKINES TNF, TGF1 IN ACUTE MYELOBLASTIC LEUKEMIA WITH SEVERITY OF CYTOPENIA Vira Barilka Received Received
  4-EP How Does Chemotherapy Affects Elderly AML Patients? Manal Aboelmagd Received Received
  5-PO Physical Isolation of Tumour Associated ctDNA Fragments for Novel AML Liquid Biopsy Maisie Spurling Received Received
  5-EP Acute Myeloid Leukaemia in Adolescents and Young Adults: A Distinct Entity? Mohamed H. Omer Received Received
  8-EP Real-World Data on Venetoclax-Based Non-Intensive Chemotherapy for AML in an Elderly, Rural Population Martha Vickers Received Received
  9-EP Precise FISH panels guided by population prevalence may assist pragmatic diagnosis of Ph-like ALL Jane Thompson Received Received
  10-EP Identifying low risk AML patients on Azacitidine and Venetoclax that do not require inpatient monitoring Verigou Eleni-Anna Received Received
  11-EP An Observational Study of AML Patients Treated with Vyxeos Chemotherapy - A Single Centre Matthew Duffy Received Received
  12-EP Long Term Outcomes of Stem-Cell-Transplant in Older Patients with AML treated with Venetoclax HMA Therapies Kathryn Moulton Received Received
  13-EP A Multiomic, Single-Cell Measurable Residual Disease (SCMRD) Assay For Phasing DNA Mutations And Surface Immunophenotypes Matteo Cattaneo Received Received
  14-EP Morbidity and Mortality Outcomes in Acute Myeloid Leukaemia Patients Treated with Venetoclax and Azacitidine Chemotherapy Francesca Leonforte Received Received
  15-EP Palliative haematology clinic for patients with Bone Marrow failure syndromes and Acute Myeloid Leukaemia. Jayne Osborne Received Received
  16-EP Review of the Acute Leukaemia Services at a District General Hospital Ethan Wong Received Received
  17-EP Real-world Experience of Venetoclax with Azacitidine or Cytarabine for the Treatment of Acute Myeloid Leukaemia Emily Sutherland Received Received
  18-EP High Survival Rate in Haematology Patients Admitted to ICU in a Tertiary Referral Centre Hannah Sadler Received Received
  18-PO Variants in Development of Pure Red Cell Aplasia & Treatment Approaches:Single Centre Study in UK Sukanya Gogoi Received Received
  19-PO Venetoclax Azacitadine as First Line Treatment for AML Real-World Data from a Multi-Centre Study Holly Gilbert Received Received
  19-EP Real-world Outcomes for Patients with Acute Myeloid Leukaemia treated with Venetoclax-Azacytidine in North of England Yashashree Gupta Received Received
  20-EP IKZF1 Deletion in Acute Lymphoblastic Leukemia: a Single-Center Experience in Thailand Suchada Sommaluan Received Received
  20-PO Elucidating the S100A4-Mediated Mechanisms Promoting AML Blast Proliferation and Survival Rehab Alanazi Received Received
  22-EP Targeting NOX2 Overexpression in Acute Myeloid Leukaemia using In Vitro Models Sian Rizzo Received Received
  22-PO The Benefit of Nurse Led Group End of Treatment Summary Sessions for Patients. Nicola Goffinet Received Received
  23-EP Phase 3b Design: Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Patients with Leukaemias Hemal Parmar Received Received
  24-EP Outcomes of Venetoclax based therapy for AML Patients - A UK DGH Real World Experience Olamide BELLO Received Received
  25-EP How Much Is Too Much? Audit of Routine Biochemistry Requests For AML Inpatients on Chemotherapy Tioluwanimi Ojeola Received Received
  26-EP Management of acute leukaemia and pregnancy outcomes in patients with current or previous leukaemia David Allsup Received Received
  27-EP Deciphering The Puzzle: Acute Leukaemias of Ambiguous Lineage Maymoona Suhail Received Received
  28-EP Are CCL19 and CCL21 the keys to unlocking dendritic cell function in paediatric B-ALL? Thomas Daley Received Received
  30-EP The relationship between early diagnosis and treatment of suspected secondary HLH (Haemophagocytic lymphohistiocytosis) on patient survival outcomes: a case series. Taran Nandra Received Received
  30-PO Exploring perceptions in management and treatment of polycythaemia vera (PV) in the UK: PV-PINPOINT study Mary Frances McMullin Received Received
  31-EP Preventative information (regarding Mucositis) given to Paediatric Patients awaiting Bone Marrow Transplants: A QI Project Alisha Amin Received Received
  32-EP Referrals to a haematology day unit: has the quality improved with a new electronic system? Sophie Ralston Received Received
  33-PO Rare MPIG6B Gene Mutation cause of refractory severe thrombocytopenia with myelofibrosis in adolescent. Muzna Aquil Received Received
  34-EP Basics to Brilliance: A Haematology Podcast for Trainees David Fasey Received Received
  35-EP Bilateral Retrobulbar Hemorrhage Causing Spontaneous Globe Subluxation in a Pediatric Patient with Factor XIII Deficiency H Shafeeq Ahmed Received Received
  36-PO Application of Prognostic Scoring in Advanced Systemic Mastocytosis patients and the Impact of Novel Therapies Priya Sriskandarajah Received Received
  37-EP Rosai-Dorfman Disease - a Rare Histiocytic Disorder : A Single Centre Experience Rosai-Dorfman Disease - A Rare Histiocytic Disorder : A Single Centre Experience. Menna Shamma Received Received
  38-EP Adhering to best practice in a nurse led myeloproliferative clinic. Emma Whitham Received Received
  39-EP Dark Web Deception: Using Laboratory Haematology to Resolve a Case of Unexplained Coagulopathy Eleanor Sheppard Received Received
  40-EP Interesting case report: Acute thrombocytopaenia following an overseas renal transplant Aoife Dervin Received Received
  40-PO An Audit of Corticosteroid use in ITP at Kings College Hospital NHS Trust Rosalind Byrne Received Received
  41-EP Peri-operative anaemia optimisation since the Covid pandemic - a service evaluation Amjad Hmaid Received Received
  41-PO Diagnosis and Treatment Patterns in European Patients with Systemic Mastocytosis Marisa Vincenti Received Received
  42-PO Burden of Systemic Mastocytosis in Europe and the UK: Interim Results from PRISM Patient Survey Marisa Vincenti Received Received
  42-EP Phase 3 Randomized Double-Blind Study Evaluating Selinexor, an XPO1 inhibitor, Plus Ruxolitinib in JAKi-Naīve Myelofibrosis Jennifer OSullivan Received Received
  43-PO A Single-site Audit of Treatment Free Remission Identification and Monitoring in Chronic Myeloid Leukaemia Patients Sophie Evans Received Received
  43-EP The Burden of Anaemia in a Primary Care Population in UK: what is Haematologys Role? Suzanne Maynard Received Received
  44-EP Exceptionally High Prevalence of Iron Deficiency Anaemia in Children Residing in Rural Areas in Pakistan Baig Aleena Received Received
  45-EP VAMPIRC: Venesection Audit in the Midlands for secondary Polycythaemia Investigating thRombotic Complications Caroline Morgan Received Received
  46-EP Outcome of bone marrow examinations in children with isolated thrombocytopenia: Experience from LMIC Visvalingam Arunath Received Received
  47-EP Hyperhaemolysis Syndrome in a Young Patient with Autoimmune Haemolytic Anaemia Nayanathara Silpage Received Received
  48-EP Quality improvement and resource optimisation - Subcutaneous Immunoglobulin for secondary immunodeficiency associated with haematological disorders Amira Chaudry Received Received
  48-PO Overview of Erythrocytosis and Thrombocytosis referrals within General Haematology clinics streamlining the MPN service Xavier Peer Received Received
  49-EP Use of Low Dose Naltrexone and Hydroxycarbamide for Mast Cell Disorders (SM, MCAS & HaT) Bethan Myers Received Received
  50-EP Investigation of Isolated Neutropenia in Childhood: Aetiology and Outcomes Eoghan Dunlea Received Received
  51-EP Treatment Free Remission in CML Patients on TKIs: An Audit From A London DGH Augustus Diaz Received Received
  52-EP Two years of the Genomic Haematology clinic: outcomes from a new service for South-West England Sarah Westbury Received Received
  54-EP Pegylated Interferon in Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ringed Sideroblasts and Marked Thrombocytosis: Single-Centre Case Series Mohammed Altohami Received Received
  55-EP Safety and Efficacy of Low Dose Pegylated Interferon (PEG-IFN) in Myeloproliferative Neoplasms: Real World Data Mamta Garg Received Received
  56-EP Detection and management of iron deficiency in pregnant women who had a major obstetric haemorrhage Adrian Choy Received Received
  56-PO Exploring Prognostic Factors in Myeloproliferative Neoplasms-associated Splanchnic Vein Thrombosis Elena Torre Received Received
  58-EP More Than Just a Number: Impact of ITP on Psychosocial QoL in Pediatric Patients Nazia Mumtaz Received Received
  59-EP Myeloproliferative Neoplasms and Thrombosis A Single Centre Retrospective Cohort Study of 111 Cases Rupen Hargreaves Received Received
  60-EP Real-World, Single-Centre Experience of Pregnancy in Patients with Philadelphia Negative Myeloproliferative Neoplasms Holly Theaker Received Received
  61-EP Chronic myelogenous leukemia presenting with Morel Lavallee lesion case report Gebeyehu Tessema Azibte Received Received
  62-EP Use of new third-line therapy for myeloproliferative neoplasm with concurrent BCR-ABL1 translocations and JAK2-V617F mutation Thais Ferrari Gersogamo Received Received
  63-EP A Real-World Patient Experiences and Quality of Life Insights Snapshot in Cold Agglutinin Disease (CAD). Kim Summers Received Received
  64-PO Deaths Attributable to Transfusion-Associated Circulatory Overload: 10-year Review of Serious Hazards Of Transfusion (SHOT) Data Oliver Firth Received Received
  64-EP Real-world electronic data in a haematology centre to better understand patient and care activity Simon Stanworth Received Received
  65-EP Stopping TKI-therapy in CML as per the BSH guidelines, an audit from a DGH practice Shyamala Chinnabhandara Received Received
  65-PO Clinical and cost effectiveness of cell salvage use in complex spinal surgery Thomas Burton Received Received
  66-PO Understanding the use of CMV-seronegative blood in allogeneic-HSCT in England Oliver Firth Received Received
  66-EP Refining Ph-MPN Diagnostic Pathways: Insights from an Audit of Wales Medical Genomics Service Leila Alwadi Received Received
  68-PO Alloimmunisation in Sickle Cell Disease: a 3-year Retrospective Study in a Tertiary Haemoglobinopathy Treatment Centre Kate Fletcher Received Received
  69-EP Patient Experience, Quality of Life and Unmet Need in UK CML Community Andrea Preston Received Received
  71-EP Navigating the Storm: Adherence and Management of Polycythaemia Vera through the COVID-19 Pandemic. Benjamin Lim Received Received
  72-EP PACIFICA: A Randomized, Phase 3 Study of Pacritinib Versus Physicians Choice in Patients with Myelofibrosis Claire Harrison Received Received
  73-PO Large Cell Transformation of Mycosis Fungoides: Patterns of Care and Patient Outcomes Philippa Johnstone Received Received
  73-EP An Audit of Use of Intravenous Immunoglobulin Therapy in Haemato-Oncology Patients Dario Melotti Received Received
  75-EP Evidence of Relevant Anaemia Response in Myelofibrosis Patients with Impaired Renal Function Treated with Momelotinib Kyaw Htin THAW Received Received
  76-EP Randomized, Open-Label Phase 3 Study of the Lysine-Specific Demethylase 1 Inhibitor Bomedemstat for Essential Thrombocythaemia Rushdia Yusuf Received Received
  76-PO Updated Results of the Safety Run-in of the Phase 3 LOTIS-5 Trial Yvonne Law Received Received
  77-EP Parathyroid hormone in plasmodium berghei infection Kavyesh Vivek Received Received
  79-EP Prevalence of ABO and RhD blood group system among blood donors in Blood Centre Batticaloa. Gauri Jayasinghe Received Received
  80-EP Influencing Change in Transfusion Information Technology Systems - the SCRIPT Survey and Collaborative Working Project Victoria Tuckley Received Received
  81-EP Role of Therapeutic Plasma Exchange in a Child with Secondary Haemophagocytic Lymphohistiocytosis Nayanathara Silpage Received Received
  82-EP Audit on the Usage of O RhD-Negative Red Cells in Emergencies in a Tertiary Hospital Sai Lon Wann Received Received
  83-EP Hematological Predictors of No-Reflow in Patients Undergoing Primary PCI For STEMI. Dr Shereen Elshazly Received Received
  83-PO Phase 2 Trial of Nanatinostat and Valganciclovir in Patients with EBV-Positive (EBV) Relapsed/Refractory Lymphomas (NAVAL-1) Jacqueline Jessie Received Received
  84-EP DNA extracted from cultured cells as a source of survey material for Molecular Haemoglobinopathy EQA Bashori Rahman Received Received
  85-PO Pirtobrutinib, a Highly Selective, Non-covalent (Reversible) BTK Inhibitor in Relapsed/Refractory Follicular Lymphoma Huseini Kagdi Received Received
  85-EP Evolving Caseload of Adult Bone Marrow Biopsies in a Specialist Integrated Haematological Malignancy Diagnostic Service jake tobin Received Received
  86-PO Pirtobrutinib in Prior cBTKi R/R MCL: Phase 1/2 BRUIN Study Updates including High-Risk Subgroup Analyses Huseini Kagdi Received Received
  86-EP Patient Consent for Blood Transfusion: An Audit Zoe Rose Received Received
  87-EP The CD47-Blocking Immune Checkpoint Inhibitor Maplirpacept Does Not Interfere with Blood Transfusion Compatibility Testing Simon Purcell Received Received
  88-EP Pathology Portal: Developing a novel, interactive education portal for Transfusion Medicine Matthew Poynton Received Received
  88-PO Infectious complications of bispecific antibody treatment in patients with lymphoproliferative disorders Abigail Martin Received Received
  90-PO Epcoritamab GemOx in ASCT-ineligible patients with R/R DLBCL: updated results from EPCORE NHL-2 David Lewis Received Received
  90-EP Insights on Erythrocyte Alloimmunization and Auto-immunization in Children from North India Manish Raturi Received Received
  91-EP CDK1 Inhibitor RO-3306 Enhances BTKi Potency in Diffuse Large B-cell Lymphoma by Suppressing JAK2/STAT3 Signaling Qiuni Chen Received Received
  92-EP Type 1 Cryoglobulinemic Vasculitis Associated with Marginal Zone Lymphoma Successfully Treated with Bendamustine and Rituximab Apurwa Prasad Received Received
  92-PO Mitigating the risk of cytokine release syndrome: EPCORE NHL-1 DLBCL cycle 1 optimization cohort results Kim Linton Received Received
  93-EP Modified DHAP Salvage Therapy for Refractory &/or Relapsed Classic Hodgkins (CHL) and Non-Hodgkins Lymphomas (NHL) Yasmine Shaaban Received Received
  94-EP Identification of Plasma lncRNA for Bone Marrow Infiltration and Staging in Diffuse Large B-Cell Lymphoma Samar Sami Elshazly Elshazly Received Received
  95-EP Diffuse B-large cell non-Hodgkins lymphoma(DBCL) associated with hepatitis B virus(HBV), clinical characteristics, therapy, and prognosis. Sergey Lepkov Received Received
  96-EP Regional Case Series of Grey Zone Lymphoma Outcomes Euan Haynes Received Received
  97-PO Awareness, Knowledge, and Acceptance of Bone Marrow Transplantation for Beta Thalassemia Major in Sri Lanka Heroshan Hasintha Jayakadu Jayakadu mudiyanselage Received Received
  98-EP DAAA therapyin patients with hepatitis C associated indolent non-Hodgkin lymphomas(HCVINHL) results of prospective study Sergey Lepkov Received Received
  99-EP Improving bone health in lymphoma- DGH experience Saima Afridi Received Received
  100-EP Patient Initiated Follow-Up in Lymphoma: Reducing clinic appointments, cost and environmental impact Emily Buchanan Received Received
  101-EP Night Sweats as a Referral Criterion for Suspected Lymphoma in the Post-COVID Era Charlotte Dawson Received Received
  102-EP A Review of a District General Hospital Lymphoma Service Before and After the COVID19 Pandemic Yen Huan Yeo Received Received
  103-PO Klebsiella Liver Abscesses in Paediatric Haemoglobinopathy Patients on Transfusion-Chelation Regimen Bethany Singh Received Received
  103-EP Epidemiological Analysis of Hodgkins Lymphoma in a Developing Middle Eastern Country Over 18 Years Ahmed Abdulelah Received Received
  104-PO Transcranial Doppler Screening of Children With Sickle Cell Disease in the HOPE Kids 2 Trial Jack Jung Received Received
  104-EP Epidemiological Analysis of Non-Hodgkins Lymphoma in a Developing Middle Eastern Country Over 18 Years Ahmed Abdulelah Received Received
  105-PO Over 4 Years of Safety and Efficacy With Voxelotor in Patients with Sickle Cell Disease Jack Jung Received Received
  105-EP A multiplexed fluorescent immunohistochemical analysis of CXCR4/CXCL12 axis in de novo and CNS B-cell lymphoma TAN JIAO JIE CHERIE Received Received
  106-EP A Child with Sporadic Burkitt lymphoma presenting as acute flaccid paralysis and capillary leak syndrome Visvalingam Arunath Received Received
  107-EP Axicabtagene Ciloleucel Real-World Manufacturing Experience in the United Kingdom Vaishali Dulobdas Received Received
  108-PO Real-World Patient Awareness Around Emerging Gene Therapies: Implications for Barriers to Access. Kim Summers Received Received
  109-PO Serum Soluble VCAM-1 is Not Associated with Severity of SCD in Adult Ghanaian Patients Willliam Ghunney Received Received
  109-EP Single Centre Experience of Personalised Stratified Follow-Up for Patients with Lymphoma Treated with Curative Intent Sapna Ladani Received Received
  110-EP Diffuse B-large cell non-Hodgkins lymphoma associated with hepatitis C (HCVDBCL): clinic and therapy results Sergey Lepkov Received Received
  111-EP Pilot for Speeding up the Diagnosis of Lymphadenopathies Gillian Flynn Received Received
  112-EP Elderly Patient With Hematological and Neurological Manifestations of Undetermined Origin: A Diagnostic Dilemma of Pernicious Anemia Anas Ibraheem Received Received
  112-PO Efanesoctocog Alfa Prophylaxis Outcomes in European Patients From the XTEND-1 Trial Mark Smith Received Received
  113-EP Preoperative Transfusion in Patients with Sickle Cell Disease: Systematic Review & Meta-analysis Khalid Elhag Mohamed Ahmed Ahmed Received Received
  114-EP Causal relations between autoimmune diseases and aplastic anemia: a bidirectional two-sample Mendelian randomization study Qiuni Chen Received Received
  114-PO Overview of the Effect of Anticoagulants on Heavy Menstrual Bleeding in Women with Thrombosis Rawya Hussein Received Received
  115-EP Severe B12 Deficiency Mimicking HELLP Syndrome; A Case Report Aneesa Rameh Received Received
  116-EP Use of Conventional Transfusion Thresholds Contribute to Iron Overload in Patients with Sickle Cell Disease Niravkumar Brahmbhatt Received Received
  118-EP METHEMOGLOBINEMIA A CASE REPORT Zahra Hasan Received Received
  119-EP Design and Implementation of sickle cell disease electronic registry in limited resources setting in Nigeria Muhammad Aminu Idris Received Received
  120-EP Minimizing Alloimmunization: Rethinking Blood Transfusions in Acute Chest Syndrome Management Melissa Friday Received Received
  121-EP Dapsone induced haemolytic anaemia and methemoglobinemia in a paediatric case study EMILY BROAD Received Received
  122-EP Between The Extremes .. A Case report of polycythemia Vera post autoimmune haemolytic anemia Asmaa Mohsen Received Received
  123-EP Management of obstetric patients with sickle cell disease a case series Ismini Panayotidis Received Received
  124-EP Is Umbilical Cord Blood a Better Treatment for Treating Paediatric Patient with Sickle Cell Disease Ebehiremen Ebhodaghe Received Received
  125-EP Treatment of Autoimmune Hemolytic Anemia in Beta Thalassemia Major Gulab Fatima Rani Received Received
  126-EP Pharmacological Intervention for Pain Management in Paediatric Sickle cell Anaemia Patient: A Network Meta-Analysis Nabiel Muhammad Haykal Received Received
  128-EP Evaluation of Some Haemostatic Parameters in Management of HBV Infection Treatment Outcome in Asaba Nigeria. Sylvia Obu Received Received
  132-EP An audit of laboratory practice conformance with guidelines for antiphospholipid tests Sophie Moores Received Received
  133-PO Real-World Data for the Efficacy and Safety of Acalabrutinib Across Two Centres in East England Edward Benn Received Received
  134-EP Hyperhomocysteinemia-associated Thrombosis in Patients With Pernicious Anemia Thura Htut Received Received
  135-EP An Audit to Assess Venous Thromboembolism Prevention Management in Pregnant/Postpartum Hospital Inpatients Clarissa Pui Received Received
  136-EP An Audit to Assess Venous Thromboembolism Prevention Management for COVID-19 Positive Hospital Inpatients Clarissa Pui Received Received
  137-EP A Review of Hospital-Associated Thrombosis with a Shared Learning Dashboard Clarissa Pui Received Received
  138-EP Von Willebrands disease and gastrointestinal angiodysplasia: a case series from a haemostasis and thrombosis centre Chloe Merrion Received Received
  139-EP Root Cause Analyses of Deaths Associated with Hospital-Acquired Venous Thromboses Over Twelve Months Kaysar Mohammadi Received Received
  140-EP Evaluation of D-dimer Cut-Off Levels for VTE Diagnosis in a Tertiary Centre Ala Bawazir Received Received
  140-PO Final Results: Phase 1b Study of Subcutaneous Isatuximab Administration by OBDS Plus Pomalidomide-dexamethasone in RRMM Nicholas Burnley-Hall Received Received
  141-PO 30-Minute Infusion of Isatuximab in Newly Diagnosed Multiple Myeloma Patients: Results of Phase 1b Study Sheetal Fermahan Received Received
  141-EP Time-in-Therapeutic Range (TTR) falls as the INR range increases in patients on warfarin Imran Malik Received Received
  142-EP Variation of monitoring for Vitamin K antagonist in antiphospholipid syndrome (APS) Saniya Khakwani Received Received
  143-EP Venous Thromboembolic Events in a Scottish District General Hospital: Variation in Management and Significant Recurrence Philippa Stimpson Received Received
  145-EP Magnetic Nanoparticles: the Possibility of Applications in the Technology of Purification of Factor VIII Coagulation Nataliya Shurko Received Received
  146-EP Audit of Comprehensive Care of Haemophilia B against World Federation of Haemophilia Guidelines. Jayna Mistry Received Received
  147-EP Antiphospholipid Syndrome Vasculopathy with Severe Aortic Stenosis Dina Osman Received Received
  148-PO Single-Cell Multi-Omic Correlation of SNVs, CNV and Surface Epitopes for Clonal Profiling of Myeloma Matteo Cattaneo Received Received
  148-EP Investigating The Utility and Clinical relevance of Thrombin Time Rishabh Motiwale Received Received
  149-EP Managing Pelvic Intraperitoneal Bleed Secondary to Ovulation in Adolescents with Congenital Bleeding Disorders. Pallav Rakesh Received Received
  151-PO Pirtobrutinib and Venetoclax Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia: Updated BRUIN Phase 1b Results Huseini Kagdi Received Received
  152-EP Cost-efficiency of home treatment/early discharge low risk patients with pulmonary embolism in a low-income country Galina Sorici Received Received
  153-EP Healthcare Resource Utilisation of Patients with VWD Treated with Recombinant Von Willebrand Factor: Chart Review Ollie Heard Received Received
  154-EP A 13-month Audit on Adherenceand Outcomes of Bridging Therapy at a UK Tertiary Centre Hassan Mahfouz Received Received
  155-EP The consequences of delayed diagnosis of pulmonary embolism, a comparative study Nadejda Diaconu Received Received
  156-EP Prospective Data Collection Project to Facilitate Audit in the Nurse-Led DVT Service Rebecca Cloudsdale Received Received
  157-EP VTE associated with N2O Use: No Laughing Matter Aizzah Mahmood Received Received
  158-EP Evaluation Astrazanica Vaccine of COVID-19 on PT, APTT Among Sudanese Vaccinated Abdelrahim Sara Received Received
  159-EP Comparison between CMV viraemia in Fully Matched and Haploidentical Stem Cell Transplants in Acute Leukaemia. Asmaa Mohsen Received Received
  160-EP Utility of PBSC collection post salvage chemotherapy for relapsed and refractory lymphomas-A single centre study Nkemdirim Ernest Jacob Received Received
  161-EP EARLY CRS PREDICTING ICANS AND ACUTE INFECTIONS PREDICTING PROGRESSION IN DLBCL PATIENTS RECEIVING CAR-T THERAPY Khalil Begg Received Received
  162-EP Integration of palliative care with CAR T services a first year experience Maimoona Ali Received Received
  163-EP Positive Complement Dependent Cytotoxicity Crossmatch following Covid 19 Vaccination in a Patient awaiting Renal Transplantation Induni Gallage Received Received
  164-EP Evaluation of Apheresis Parameters for Optimal Autologous Peripheral Blood Stem Cell Harvesting from Lymphoma Patients Dilupa Gunasekara Received Received
  165-EP Characteristics, prognostic indicators and survival Among Omani Patients Diagnosed With Chronic Lymphoid Leukemia at SQUH Salim Al Ruqeishi Received Received
  166-EP Rituximab Prior To Venetoclax Is Safe And Effective In Relapsed/Refractory Chronic Lymphocytic Leukemia Peter Johnstone Received Received
  167-EP A Retrospective Review of SPEP Testing Practices and MGUS diagnosis in a Community Hospital Chun Siu Received Received
  168-EP Diagnostics and treatment in AL Amyloidosis with Cardiac Involvement- A Dual Centre Retrospective Cohort Study Ewan Evans Received Received
  169-EP Investigating Infection in Multiple Myeloma Patients on Anti-CD38 Monoclonal Antibody Treatment Hannah Furness Received Received
  170-EP Triple Class Refractory Patient and Carer Experience of Living with Multiple Myeloma Noreen Ali Received Received
  172-EP Switching From Covalent BTKi to BCL2i Improves Outcomes Versus Using a Sequential BTKi in CLL/SLL bernadette lazar Received Received
  173-EP Venetoclax; Implementation of Out-Patient Monitoring Tracey Arthur Received Received
  174-EP Beyond Hospital Doors- Bringing Cancer Treatment to the patients own home; The Rotherham Experience Suhani Ghiya Received Received
  175-EP A snapshot of UK clinical trial activity in myeloma: reflections on recruitment and patient experience Rhys Owens Received Received
  176-EP Management of Monoclonal Gammopathy of Undetermined Significance Patient Group, by Haematology Advanced Nurse Practitioners. Katharine Hanlon Received Received
  177-EP Real World Characteristics and Outcomes for Triple Class Exposed Myeloma Patients on Pomalidomide and Dexamethasone Carmen Tsang Received Received
  178-EP Characteristics of Newly Diagnosed Myeloma Patients With and Without Transplant: Real-world Big Data From England Sheetal Fermahan Received Received
  179-EP A matching-adjusted indirect comparison of ELEVATE-TN versus SEQUOIA: in treatment-naīve chronic lymphocytic leukemia. Miguel Miranda Received Received
  180-EP Real-World Outcomes of Triple-Class Exposed Patients with Relapsed Multiple Myeloma in England: Follow-up Analysis Annie LIED-LIED Received Received
  181-EP Multiple Myeloma with Central Nervous System Disease: Three Cases From Nottingham City Hospital Jennifer Ryan Received Received
  182-EP Paraneoplastic Granulocyte Colony-Stimulating Factor Secretion in a Patient with Multiple Myeloma - A Case Report. Rebekah Picken Received Received
  183-EP Audit of thromboprophylaxis prescription in multiple myeloma patients receiving immunomodulatory-drug therapy Niharika Manu Received Received
  184-EP Incidentalomas in patients with multiple myeloma, MGUS, and plasmacytomas - results of 150 PET-CTs Catherine Chinnery Received Received
  185-EP Teclistamab Monotherapy First Experience in Patient with Refractory Multiple Myeloma in Russia Stanislav Kamyshanov Received Received
  186-EP Newly Diagnosed Multiple Myeloma VRD Protocol Treatment Precursory Results Arman Arakelyan Received Received
  187-EP Venetoclax Obinutuzumab for Chronic Lymphocytic Leukaemia: Is stringent TLS monitoring proportional to risk? Thomas Mayo Received Received
  188-EP EPIC: A Non-Interventional Cohort Study of Patients with Chronic Lymphocytic Leukaemia Treated with First-Line Acalabrutinib Renata Walewska Received Received
  189-EP Experience of the use of Belantamab Mafodotin in a UK Teaching Hospital Aritri Mandal Received Received
  190-EP Venetoclax Effectiveness After Bruton Tyrosine Kinase Inhibitors In Chronic Lymphocytic Leukaemia: An International Real-World Study bernadette lazar Received Received
  191-EP Myeloma masquerading as Myeloproliferative Neoplasm (MPN) A Case Report Katarina Flatman Received Received
  192-EP Single-centre outcomes for high and ultra-high risk myeloma patients since the introduction of lenalidomide maintenance Jennifer Ryan Received Received
  193-EP Pirtobrutinib in Post-cBTKi CLL/SLL With/Without Prior BCL2i: Phase 1/2 BRUIN Study 30 Months Follow-Up Analysis Huseini Kagdi Received Received
  194-EP Genomic Evolution/Resistance during Pirtobrutinib therapy in Covalent BTK-Inhibitor (cBTKi) Pre-treated Chronic Lymphocytic Leukemia Patients (Update) Huseini Kagdi Received Received
  196-EP Assigning Disease Risk in New Multiple Myeloma: Improving Practice to Prepare for Risk-Adaptive Treatment Strategies Amalachukwu Nwosu Received Received
  197-EP Impact of Obesity on Melphalan Dosing in Myeloma Patients undergoing Autologous Stem Cell Transplantation. Imogen Welding Received Received
  198-EP Real-World Experience of Implementation of Quadruplet Chemotherapy for Myeloma Patients in an NHS Cancer Centre. Salam Youssef Received Received
  199-EP Initial findings from a first-in-human Phase 1a/b trial of NX-5948, a ive BTK degrader Lee Miller Received Received
  200-EP Targeted Use of RNA Fusion Panels in the Diagnostic Work-Up of Selected Haematological Malignancies Oliver Firth Received Received
  201-EP Is It A Major Or Minor Problem? Transfusion Errors In Haemopoietic Stem Cell Transplants 2011-2022 Victoria Tuckley Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
13:27
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

64th Annual Scientific Meeting of the British Society for Haematology

 

28-30 April Liverpool
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 28/04/2024 TO 28/04/2025
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                  




PosterSessionOnline
Logo Draft
 
Logo Cert